Reaction

Vitreous Adhesions reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 113 reports · 2 co-occurring drugs

As of the last recalculation, Vitreous Adhesions appears in 113 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 138.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ranibizumab17138.7138.8
Aflibercept850.850.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.